SOMATOTROPIN LEVEL IN LONG-TERM ANTIHYPERTENSIVE TREATMENT
Abstract
Changes in plasma STH in long-term (12 months) drug treatment of essential hypertension (EH) with Nadolol, Propranolol, Prazosine, Hydrochlorothiazide have been studied in 104 men with EH II degree according to the WHO classification. Treatment with Propranolol and Nadolol led to increased plasma STH in the first 2 months of treatment, particularly in subjects with baseline increase and long-term history of EH. Mean plasma STH levels decrease to a greater extent with increasing duration of drug intake. Treatment with hydrochlorothiazide is generally accompanied by no relaible shift in plasma STHlevel, but may lead to increased plasma STH level in young subjects (below 50years of age).
About the Author
I. I. MustafayevRussian Federation
References
1. Karlberg B.E., Ottossen A.-M. Acromegaly and hypertension: role of renin-angiotensin-aldosteron system.//Acta endocrinol. 1982. V. 100, N 4. P. 581-587.
2. O'kufe J. C., Grant S.J., Wiseman J.C., et al. Acromegaly and the heart -Echocardiography and nuclear imaging studies.//Acta N.Z.J. Med. 1982. V. 12, N 6. P. 603-606.
3. В.И. Метелица, Н.П. Филатова. Рабочая группа КИППАГ. Результаты сравнительного изучения надолола, пропранолола, празозина и гидрохлортиазида у больных артериальной гипертонией при 12-месячном лечении по ступенчатой схеме (кооперативное исследование). Сообщение I: Протокол исследования, результаты монотерапии.//Тер. архив. 1991. № 8. С. 30-34.
4. В.И. Метелица, Н.П. Филатова. Рабочая группа КИППАГ. Результаты сравнительного изучения надолола, пропранолола, празозина и гидрохлортиазида у больных артериальной гипертонией при 12-месячном лечении по ступенчатой схеме (кооперативное исследование). Сообщение II: Результаты комбинированной терапии. Побочные действия. Причина выбытия. Заключение.//Тер. архив. 1991. № 8. C. 35-42.
5. Arosio M., Losa M., Bazzoni N., et al. Effects of propranolol on GH responosivness to trepeated GH-releasing hormone stimulation in normal subjects.//Aсta Endocrinol. (Copenh). 1990. V. 122, N 6. P. 735-739.
6. Imura H., Kato Y., Ikeda M., et al. Effect of adrenergic-blocking or stimulating agents on plasma growth hormone, imunreactive insulin, and blood free fatty levels in man.//J. Clin. Invest. 1971. V. 50. P. 1069-1079.
7. Pannier J.L., Calders P., Eechaute W. Effect of adrenergic receptor blockade on plasma testosterone response to exercise in conscious dogs.//Arc. Inter. Physiol. Biochim. Biophys. 1994. V. 102. P. 195-198.
8. Paradisi R., Venturoli S., Copelli M., et al. Effects of alpha-adrenergic blockade on pulsatile luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in polycystic ovary syndrome.//Clin. Endo-crinol. Metab. 1987. V. 5. P. 841-946.
9. Ishibashi M., Yamaji T. Direct effects of catecholamines thyreotropin-releasing hormone and prolactin secretion from adenomatous pituitary cells in culture.//J. Clin. Invest. 1984. V. 73, N 1. P. 66-78.
10. Grufeld C., Sherman B.M., Cavalieri R.R. The acute effects of human growth hormone administration on thyroid function in normal men.//J. Clin. Endocrinol. Metab. 1988. V. 67, N 5. P. 1111-1114.
11. Yu-Kai Sun, Yu-Ping Xi, Fenoglio C.M., et al. The efect of age on the number of pituitary cells immunoreactive to growth hormone and prolactin.//Hum. Pathol. 1984. V. 15, N 2. P. 169-180.
12. Radek J., Marek J. Hormone induced cardiomiopathies. In: Proceedings of the 16th World Congress ISIM. F. Kolbel, V. Parovsky eds. Avicenum. Praha. 1983. P. 165-182.
13. Mace P.J. E., Litter W.A., Glove D.R., et al. Regresson of left ventricular hypertrophy in hypertentsion: comparative effects of three different drugs.//J. Cardiovasc. Pharmacol. 1985. V. 7, Suppl. 2. P. S52-S55.
14. Шрейбер В. Патофизиология желез внутренней секреции. Авиценум. Прага, 1987. С. 3-493.
15. Ahren В., Lunqunist I. Effects of selective and nonselective (β-adrenergic agents on insulin secretion in vivo.//Eur. J. Pharmacol. 1981. V. 71. P. 93-104.
16. Мустафаев И.И. Влияние гипотензивных средств на липиды крови: Автореф. дис.... канд. мед. наук. М., 1985.
Review
For citations:
Mustafayev I.I. SOMATOTROPIN LEVEL IN LONG-TERM ANTIHYPERTENSIVE TREATMENT. Russian Journal of Cardiology. 2003;(4):63-66. (In Russ.)